210 related articles for article (PubMed ID: 36806439)
1. Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study.
Lovett SM; Sandler DP; O'Brien KM
J Natl Cancer Inst; 2023 Jun; 115(6):662-670. PubMed ID: 36806439
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer rate after oophorectomy: A Prospective Danish Cohort Study.
Koch T; Jørgensen JT; Christensen J; Dehlendorff C; Priskorn L; Simonsen MK; Duun-Henriksen AK; Andersen ZJ; Juul A; Bräuner EV; Hickey M
Int J Cancer; 2021 Aug; 149(3):585-593. PubMed ID: 33729548
[TBL] [Abstract][Full Text] [Related]
3. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
4. Associations of Premenopausal Hysterectomy and Oophorectomy With Breast Cancer Among Black and White Women: The Carolina Breast Cancer Study, 1993-2001.
Robinson WR; Nichols HB; Tse CK; Olshan AF; Troester MA
Am J Epidemiol; 2016 Sep; 184(5):388-99. PubMed ID: 27555487
[TBL] [Abstract][Full Text] [Related]
5. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study.
Gottschau M; Kjær SK; Settnes A; Aalborg GL; Bens A; Jensen A; Munk C; Mellemkjær L
Breast Cancer Res Treat; 2020 Jun; 181(2):475-485. PubMed ID: 32328847
[TBL] [Abstract][Full Text] [Related]
6. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
[TBL] [Abstract][Full Text] [Related]
7. Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk.
Cui Y; Deming-Halverson SL; Beeghly-Fadiel A; Lipworth L; Shrubsole MJ; Fair AM; Shu XO; Zheng W
Clin Cancer Res; 2014 Mar; 20(5):1169-78. PubMed ID: 24423614
[TBL] [Abstract][Full Text] [Related]
8. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
9. Bilateral oophorectomy and rate of colorectal cancer: A prospective cohort study.
Koch T; Therming Jørgensen J; Christensen J; Duun-Henriksen AK; Priskorn L; Kildevaeld Simonsen M; Dehlendorff C; Jovanovic Andersen Z; Juul A; Bräuner EV; Hickey M
Int J Cancer; 2022 Jan; 150(1):38-46. PubMed ID: 34449872
[TBL] [Abstract][Full Text] [Related]
10. Bilateral oophorectomy and risk of cancer in African American women.
Boggs DA; Palmer JR; Rosenberg L
Cancer Causes Control; 2014 Apr; 25(4):507-13. PubMed ID: 24487726
[TBL] [Abstract][Full Text] [Related]
11. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications.
Chow S; Raine-Bennett T; Samant ND; Postlethwaite DA; Holzapfel M
Am J Obstet Gynecol; 2020 Dec; 223(6):900.e1-900.e7. PubMed ID: 32585221
[TBL] [Abstract][Full Text] [Related]
13. Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer.
Nichols HB; Trentham-Dietz A; Newcomb PA; Egan KM; Titus LJ; Hampton JM; Visvanathan K
Breast Cancer Res; 2013; 15(5):R99. PubMed ID: 24152546
[TBL] [Abstract][Full Text] [Related]
14. Risk of de novo cancer after premenopausal bilateral oophorectomy.
Huo N; Smith CY; Gazzuola Rocca L; Rocca WA; Mielke MM
Am J Obstet Gynecol; 2022 Apr; 226(4):539.e1-539.e16. PubMed ID: 34774521
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.
Shufelt C; Bairey Merz CN; Pettinger MB; Choi L; Chlebowski R; Crandall CJ; Liu S; Lane D; Prentice R; Manson JE;
Menopause; 2018 Sep; 25(9):985-991. PubMed ID: 29738414
[TBL] [Abstract][Full Text] [Related]
16. Hysterectomy With and Without Oophorectomy, Tubal Ligation, and Risk of Cardiovascular Disease in the Nurses' Health Study II.
Farland LV; Rice MS; Degnan WJ; Rexrode KM; Manson JE; Rimm EB; Rich-Edwards J; Stewart EA; Cohen Rassier SL; Robinson WR; Missmer SA
J Womens Health (Larchmt); 2023 Jul; 32(7):747-756. PubMed ID: 37155739
[No Abstract] [Full Text] [Related]
17. Body mass index following natural menopause and hysterectomy with and without bilateral oophorectomy.
Gibson CJ; Thurston RC; El Khoudary SR; Sutton-Tyrrell K; Matthews KA
Int J Obes (Lond); 2013 Jun; 37(6):809-13. PubMed ID: 23007036
[TBL] [Abstract][Full Text] [Related]
18. Hysterectomy, oophorectomy, estrogen, and the risk of dementia.
Rocca WA; Grossardt BR; Shuster LT; Stewart EA
Neurodegener Dis; 2012; 10(1-4):175-8. PubMed ID: 22269187
[TBL] [Abstract][Full Text] [Related]
19. Premenopausal gynecologic surgery and survival among black and white women with breast cancer.
Roberson ML; Nichols HB; Olshan AF; A Troester M; Robinson WR
Cancer Causes Control; 2020 Feb; 31(2):105-112. PubMed ID: 31828465
[TBL] [Abstract][Full Text] [Related]
20. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.
Parker WH; Broder MS; Chang E; Feskanich D; Farquhar C; Liu Z; Shoupe D; Berek JS; Hankinson S; Manson JE
Obstet Gynecol; 2009 May; 113(5):1027-1037. PubMed ID: 19384117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
